Literature DB >> 23032926

Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center.

K J Price1, M Cardenas-Turanzas, H Lin, L Roden, R Nigam, J L Nates.   

Abstract

BACKGROUND: The prognosis for adult acute leukemia patients that require intensive care unit (ICU) admission and invasive mechanical ventilation is poor. We aimed to identify prognostic indicators of 30-day hospital mortality in adult patients who had acute leukemia and respiratory failure, who had received invasive mechanical ventilation in the ICU but who had not received blood and marrow transplantation, were not admitted due to cardiopulmonary arrest or myocardial infarction and, had not recently undergone surgery.
METHODS: In this case-control study, we retrospectively reviewed the medical records of relevant patients >16 year old who had been admitted to the ICU at our institution over a 4-year period. The main outcome measure was 30-day hospital mortality. Univariate and multivariate analyses were conducted to determine significant predictors of death.
RESULTS: For the 167 patients meeting our eligibility criteria, the median age was 61 years. The majority was admitted due to respiratory insufficiency/failure (69%). The 30-day hospital mortality rate was 62%. Independent predictors of 30-day hospital mortality were advanced disease status (odds ratio [OR]=3.34; 95% confidence interval [CI], 1.65-6.77) and increased organ failure at the time of intubation (OR=1.17; 95% CI, 1.03-1.33) per point increase in the SOFA score. Patients who had received endotracheal intubation within the first 24 h of ICU admission were less likely than others to die (OR=0.46, 95% CI, 0.23-0.91) within the next 30 days after admission to the hospital.
CONCLUSION: Advanced disease status and elevated SOFA scores at intubation are strong predictors of 30-day mortality in patients with acute leukemia and respiratory failure. The protective effect of early endotracheal intubation warrants further investigation.

Entities:  

Mesh:

Year:  2012        PMID: 23032926      PMCID: PMC3935771     

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  24 in total

Review 1.  Pulmonary complications following bone marrow transplantation.

Authors:  C K Chan; R H Hyland; M A Hutcheon
Journal:  Clin Chest Med       Date:  1990-06       Impact factor: 2.878

2.  The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction.

Authors:  Daliana Peres Bota; Christian Melot; Flavio Lopes Ferreira; Vinh Nguyen Ba; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2002-09-06       Impact factor: 17.440

Review 3.  Allogeneic marrow transplantation.

Authors:  K M Sullivan; R Storb
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

4.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

Review 5.  Pulmonary complications of bone marrow transplantation.

Authors:  M J Krowka; E C Rosenow; H C Hoagland
Journal:  Chest       Date:  1985-02       Impact factor: 9.410

6.  Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure.

Authors:  Pieter O Depuydt; Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Francis A Colardyn
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

7.  Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy.

Authors:  D P Schuster; J M Marion
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

8.  Acute respiratory failure in severe hematologic disorders.

Authors:  R Estopa; A Torres Marti; N Kastanos; A Rives; A Agusti-Vidal; C Rozman
Journal:  Crit Care Med       Date:  1984-01       Impact factor: 7.598

9.  Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; I Wright; T A Lister; C J Hinds
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

10.  Outcome of respiratory failure in hematologic malignancy.

Authors:  S G Peters; J A Meadows; D R Gracey
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

View more
  4 in total

1.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

Review 2.  A systematic review of prognostic factors at the end of life for people with a hematological malignancy.

Authors:  Elise Button; Raymond Javan Chan; Shirley Chambers; Jason Butler; Patsy Yates
Journal:  BMC Cancer       Date:  2017-03-23       Impact factor: 4.430

3.  Epidemiology, Clinical Characteristics, and Prognostic Factors in Critically Ill Patients with Hematolymphoid Malignancy.

Authors:  Suhail S Siddiqui; Natesh R Prabu; Harish K Chaudhari; Amit M Narkhede; Satish V Sarode; Ujwal Dhundi; Jigeeshu V Divatia; Atul P Kulkarni
Journal:  Indian J Crit Care Med       Date:  2021-01

4.  Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care Unit.

Authors:  Alan P Kraguljac; Danielle Croucher; Michael Christian; Narmin Ibrahimova; Vikram Kumar; Gabriella Jacob; Alex Kiss; Mark D Minden; Sangeeta Mehta
Journal:  Can Respir J       Date:  2016-06-30       Impact factor: 2.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.